跳轉至內容
Merck
  • A new antiinflammatory agent (EGIS-5645) without gastrointestinal side-effect.

A new antiinflammatory agent (EGIS-5645) without gastrointestinal side-effect.

Agents and actions. Supplements (1991-01-01)
G Gigler, E Kiszelly, P Tömpe, G Kovács, K Gadó
摘要

The compound EGIS-5645 is a potent antipyretic agent possessing analgesic and antiinflammatory properties. The drug is active in antiinflammatory models such as carrageenin oedema and adjuvant arthritis. EGIS-5645 shows practically no gastro-ulcerogenic effect. The molecule does not inhibit either prostaglandin biosynthesis or soybean lipoxygenase enzyme activity.

材料
產品編號
品牌
產品描述

Supelco
敌菌净, analytical standard, ≥99.0% (TLC)